NCT00006292View on ClinicalTrials.gov

Infliximab for the Treatment of Early Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

September 30, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Infliximab

Trial Locations (1)

20892

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00006292 - Infliximab for the Treatment of Early Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter